An interventional study of Dry Needling Acupuncture in Myofascial Pain Syndrome, sponsored by Universitas Indonesia. Not yet recruiting at 1 site in Indonesia. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by Universitas Indonesia · Not applicable, Interventional, and Treatment
This study aims to evaluate the immediate effects of a single session of dry needling on pain intensity and pressure pain threshold in patients with myofascial pain syndrome of the upper trapezius muscle. Outcomes will be assessed using the Numeric Rating Scale (NRS) and Pressure Pain Threshold (PPT) at baseline and at 30 minutes, 24 hours, and 72 hours after treatment.
Myofascial pain syndrome (MPS) is a regional pain condition involving muscles, fascia, and surrounding soft tissues and is commonly associated with myofascial trigger points (MTrPs). The upper trapezius muscle is a frequent site of MTrPs and may be associated with neck and shoulder pain, muscle stiffness, and functional limitations.
Dry needling is a minimally invasive acupuncture technique that uses a sterile filiform needle without the administration of pharmacological substances. The needle is inserted into the identified myofascial trigger point with the aim of providing mechanical stimulation and inducing a local twitch response. These effects may contribute to the reduction of MTrP irritability and pain through mechanical and neurophysiological mechanisms.
This study is designed as a quasi-experimental study using a one-group pretest-posttest design. The study will be conducted at the Medical Acupuncture Clinic of RSUPN Persahabatan, Jakarta, from August to December 2026. The study will include adult participants aged 18-59 years with posterior neck and shoulder pain, a myofascial trigger point in the upper trapezius muscle, a baseline Numeric Rating Scale (NRS) score of 4-6, and a Pressure Pain Threshold (PPT) of ≤3 kg.
Eligible participants who provide written informed consent will undergo a single session of dry needling. The intervention will be performed by a medical acupuncture resident of the Faculty of Medicine, Universitas Indonesia, with competency level 3. A sterile acupuncture needle measuring 0.25 × 40 mm will be inserted into the identified myofascial trigger point of the upper trapezius muscle at a 90-degree angle to the skin surface in the superior-inferior direction. Fast-in and fast-out needle manipulation will be performed for a maximum of three times or until one local twitch response occurs. The needle will then be immediately removed without retention.
Pain intensity and pressure pain threshold will be assessed immediately before the intervention and at 30 minutes, 24 hours, and 72 hours after the intervention. Pain intensity will be measured using the Numeric Rating Scale (NRS), ranging from 0 to 10, with higher scores indicating greater pain intensity. Pressure pain threshold will be measured using an algometer at the identified anatomical site, and the value will be recorded at the point when the participant first reports a sensation of pain.
The primary outcomes of interest are changes in NRS and PPT from baseline following the dry needling intervention. The study will evaluate changes at 30 minutes, 24 hours, and 72 hours after treatment.
Participants will also be monitored for adverse effects associated with the procedure. Following the intervention, participants will receive instructions regarding post-procedure care, including avoiding massage of the treated area and heavy shoulder loading, performing stretching exercises, maintaining ergonomic posture, and using a cold compress if discomfort occurs.
Data will be analyzed using SPSS version 25.0. Numerical variables will be assessed for normality using the Shapiro-Wilk test. For normally distributed paired data, the paired t-test will be used, while the Wilcoxon signed-rank test will be used for non-normally distributed data. Statistical significance will be defined as p \< 0.05.
339 studies on the registry are indexed under Myofascial Pain Syndromes; 66 are open to participants now.
This study's planned enrollment of 30 is below the median of 50 across 307 interventional studies indexed under Myofascial Pain Syndromes.
Browse Myofascial Pain Syndromes studies →Universitas Indonesia is the lead sponsor of 35 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Dry Needling Acupuncture
Device: Dry Needling Acupuncture
The procedures will be done once, and outcomes will be evaluated at 30 minutes, 24 hours, and 72 hours after treatment.
Pain Intensity Measured by the Numeric Rating Scale (NRS)
The Numeric Rating Scale (NRS) measures self-reported pain intensity. The NRS is an 11-point numerical scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants select the number that best represents their pain intensity at the time of assessment. Higher scores indicate greater pain intensity. The outcome is the change in NRS pain intensity from baseline to immediately after the dry needling intervention.
Time frame: baseline, 30 minutes, 24 hours, and 72 hours after treatment
Change in Pressure Pain Threshold (PPT) of the Upper Trapezius Muscle
Pressure Pain Threshold (PPT) is an objective measure of pressure pain sensitivity in deep muscular tissue. PPT is defined as the minimum amount of externally applied pressure at which a gradually increasing, non-painful pressure stimulus is first perceived as painful. PPT will be measured using a pressure algometer applied to the specified measurement point in the upper trapezius muscle. The pressure will be increased gradually until the participant reports the onset of pain. The pressure value at the onset of pain will be recorded. Higher PPT values indicate lower pressure pain sensitivity, whereas lower PPT values indicate greater pressure pain sensitivity. The outcome measure is the change in PPT from baseline to immediately after the dry needling intervention.
Time frame: baseline, 30 minutes, 24 hours, and 72 hours after treatment
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitas Indonesia